Jennifer Kayden Lee, EVP, Head of North America: Rhythm Pharmaceuticals RYTM Sell · Filed 25/02/19

Trade details

Type: Insider sale
Amount: $116,442.7
Shares · price: 2,035 sh · $57.22 a share
Held after: 5,858 sh
Stock: Rhythm Pharmaceuticals RYTM
Person: Jennifer Kayden LeeEVP, Head of North America
Trade date: 25/02/19
Filed: 25/02/19
Days to filing: 0 days

Sold 25.8% of holdings

Share of holding sold: 25.8%

Rhythm Pharmaceuticals trades, last 26 weeks

What else happened in Rhythm Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/01/20~25/03/21

Jennifer Kayden Lee's recent trades

Jennifer Kayden LeeEVP, Head of North America
Planned sale10b5-1 planRhythm Pharmaceuticals
Planned sale10b5-1 plan
Rhythm Pharmaceuticals
RYTM
$8.9M
75,834 sh
$8.9M
Filed 08/13
Traded 08/13
Jennifer Kayden LeeEVP, Head of North America
Sell10b5-1 planRhythm Pharmaceuticals
Sell10b5-1 plan
Rhythm Pharmaceuticals
RYTM
$69.9K
1,205 sh
$69.9K
Filed 25/02/14
Traded 25/02/13
Jennifer Kayden LeeEVP, Head of North America
Sell10b5-1 planRhythm Pharmaceuticals
Sell10b5-1 plan
Rhythm Pharmaceuticals
RYTM
$67.9K
1,205 sh
$67.9K
Filed 25/02/14
Traded 25/02/12
Jennifer Kayden LeeEVP, Head of North America
Sell10b5-1 planRhythm Pharmaceuticals
Sell10b5-1 plan
Rhythm Pharmaceuticals
RYTM
$33.8K
600 sh
$33.8K
Filed 25/02/14
Traded 25/02/12
Jennifer Kayden LeeEVP, Head of North America
Sell10b5-1 planRhythm Pharmaceuticals
Sell10b5-1 plan
Rhythm Pharmaceuticals
RYTM
$564
10 sh
$564
Filed 25/02/14
Traded 25/02/12

Jennifer Kayden Lee, EVP — sold $116.4K of Rhythm Pharmaceuticals RYTM · 25.8% of holdings · 10b5-1 plan | Whalegun